Does NIRAPARIB Cause Red cell distribution width increased? 89 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 89 reports of Red cell distribution width increased have been filed in association with NIRAPARIB (ZEJULA). This represents 0.4% of all adverse event reports for NIRAPARIB.
89
Reports of Red cell distribution width increased with NIRAPARIB
0.4%
of all NIRAPARIB reports
8
Deaths
19
Hospitalizations
How Dangerous Is Red cell distribution width increased From NIRAPARIB?
Of the 89 reports, 8 (9.0%) resulted in death, 19 (21.3%) required hospitalization, and 21 (23.6%) were considered life-threatening.
Is Red cell distribution width increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NIRAPARIB. However, 89 reports have been filed with the FAERS database.
What Other Side Effects Does NIRAPARIB Cause?
Nausea (5,794)
Fatigue (5,240)
Constipation (4,128)
Platelet count decreased (4,102)
Insomnia (2,861)
Blood pressure increased (2,464)
Headache (2,383)
Off label use (2,213)
Vomiting (2,029)
Carbohydrate antigen 125 increased (1,868)
What Other Drugs Cause Red cell distribution width increased?
CLOZAPINE (439)
METHOTREXATE (210)
ALEMTUZUMAB (202)
RITUXIMAB (198)
PREDNISONE (178)
PALBOCICLIB (171)
ADALIMUMAB (144)
METHYLPREDNISOLONE (123)
ECULIZUMAB (110)
TOCILIZUMAB (108)
Which NIRAPARIB Alternatives Have Lower Red cell distribution width increased Risk?
NIRAPARIB vs NIRMATRELVIR\RITONAVIR
NIRAPARIB vs NIROGACESTAT
NIRAPARIB vs NIROGACESTAT HYDROBROMIDE
NIRAPARIB vs NIRSEVIMAB
NIRAPARIB vs NIRSEVIMAB-ALIP